Inibidores
Os inibidores são moléculas que se ligam a enzimas, receptores ou outras proteínas para reduzir ou bloquear sua atividade biológica. Esses compostos são amplamente utilizados em pesquisas para estudar vias biológicas, entender mecanismos de doenças e desenvolver medicamentos terapêuticos. Os inibidores desempenham um papel crucial no tratamento de várias doenças, incluindo câncer, doenças cardiovasculares e infecções. Na CymitQuimica, oferecemos uma ampla gama de inibidores de alta qualidade para apoiar sua pesquisa em bioquímica, biologia celular e desenvolvimento farmacêutico.
Subcategorias de "Inibidores"
- Angiogénese(2.519 produtos)
- Apoptose(5.787 produtos)
- Ciclo celular/Ponto de verificação(4.446 produtos)
- Cromatina/Epigenética(2.235 produtos)
- Sinalização Citoesquelética(1.381 produtos)
- Dano de DNA/Reparo de DNA(2.824 produtos)
- Endocrinologia/Hormónios(3.500 produtos)
- Enzima(3.639 produtos)
- GPCR/Proteína-G(8.318 produtos)
- Imunologia e Inflamação(3.516 produtos)
- Vírus da Influenza(296 produtos)
- Sinalização JAK/STAT(404 produtos)
- Sinalização MAPK(1.200 produtos)
- Transportador de Membranas/Canal Iónico(2.787 produtos)
- Metabolismo(9.416 produtos)
- Microbiologia/Virologia(6.968 produtos)
- Neurociência(9.920 produtos)
- Outros inibidores(37.928 produtos)
- Oxidação-Redução(41 produtos)
- Sinalização PI3K/Akt/mTOR(1.400 produtos)
- Proteases/Proteassoma(1.596 produtos)
- Células - tronco e Derivados(831 produtos)
- Tirosina Quinase/Adaptador(2.015 produtos)
- Ubiquitinação(1.649 produtos)
Exibir 16 mais subcategorias
Foram encontrados 66627 produtos de "Inibidores"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
BET-IN-15
CAS:<p>BET-IN-15 (compound 1) is a potent, orally active inhibitor of BET, demonstrating inhibitory IC50 values of 0.64 nM for BRD4-BD1 and 0.25 nM for BRD4-BD2.</p>Fórmula:C21H18F2N4O3SPureza:98%Cor e Forma:SolidPeso molecular:444.45Ref: TM-T79167
Produto descontinuadoRadafaxine hydrochloride
CAS:<p>Radafaxine hydrochloride is an inhibitor of DAT and NET transporters, and nAChR family modulator.</p>Fórmula:C13H19Cl2NO2Pureza:98%Peso molecular:292.2AKOS-22
CAS:<p>AKOS-22: potent VDAC1 inhibitor, Kd=15.4 μM; prevents mitochondrial dysfunction and apoptosis.</p>Fórmula:C22H21ClF3N3O3Pureza:98%Cor e Forma:SolidPeso molecular:467.87Mavodelpar free base
CAS:<p>Mavodelpar free acid (REN001 free acid) is an selective agonist of PPARδ.</p>Fórmula:C31H30FNO5Pureza:98%Cor e Forma:SolidPeso molecular:515.57Questiomycin A derivatives 18 TFA
<p>Questiomycin A derivative 18 TFA exhibits antibacterial, anticancer properties and inhibits GRP78.</p>Fórmula:C16H12F3N3O5Pureza:98.45%Cor e Forma:SoildPeso molecular:383.07Ref: TM-T67717L
Produto descontinuadoBromadoline maleate
CAS:<p>Bromadoline is an opioid analgesic selective for the μ-opioid receptor.</p>Fórmula:C19H25BrN2O5Pureza:98%Cor e Forma:SolidPeso molecular:441.322UBP1112
CAS:<p>group III mGlu receptor antagonist</p>Fórmula:C10H14NO5PPureza:98%Cor e Forma:SolidPeso molecular:259.2PAD4-IN-2
CAS:<p>PAD4-IN-2 (compound 5i) is a PAD4 inhibitor with an IC50 value of 1.94 μM, shown to suppress tumor growth in mice through specific inhibition of the PAD4-H3cit-</p>Fórmula:C20H23BClN7O6Cor e Forma:SolidPeso molecular:503.7HBV-IN-34
CAS:<p>HBV-IN-34 (compound 17i) is a potent inhibitor of HBsAg production, demonstrating remarkable in vitro anti-HBV efficacy with EC50 values of 0.018 μM for HBV DNA</p>Fórmula:C21H19F2N7Pureza:98%Cor e Forma:SolidPeso molecular:407.42Ref: TM-T79469
Produto descontinuadoFosfonet sodium
CAS:<p>Fosfonet sodium is a sodium salt of phosphonoacetic acid, effective against herpesviruses by inhibiting viral DNA polymerase.</p>Fórmula:C2H4NaO5PCor e Forma:SolidPeso molecular:162.01KP372-1
CAS:<p>KP372-1, an Akt inhibitor, blocks PI3K signaling, arrests cell growth, and triggers apoptosis in head/neck squamous cell carcinoma.</p>Fórmula:C20H8N12O2Cor e Forma:SolidPeso molecular:448.36Phenazolam
CAS:<p>Phenazolam is an analytical reference standard categorized as a benzodiazepine. [1] This product is intended for research and forensic applications.</p>Fórmula:C17H12BrClN4Cor e Forma:SolidPeso molecular:387.66HPK1-IN-18
CAS:<p>HPK1-IN-18: Potent, specific inhibitor of HPK1, a MAP4K enzyme, for cancer research and treatment.</p>Fórmula:C24H24N4Cor e Forma:LiquidPeso molecular:368.47ALPK1-IN-1
CAS:<p>ALPK1-IN-1 (A001) strongly inhibits ALPK1, key for innate immunity & NF-κB signaling via TIFA/TRAF.</p>Fórmula:C25H32N6O2SCor e Forma:SolidPeso molecular:480.63PKUMDL-LTQ-301
CAS:PKUMDL-LTQ-301 is a potent inhibitor of HipA toxin. PKUMDL-LTQ-301 also inhibits E. coli persistence.Fórmula:C30H28N2O4Pureza:98%Cor e Forma:SolidPeso molecular:480.55Pazinaclone
CAS:<p>Pazinaclone is a non-benzodiazepine (GABAA) partial agonist with sedative and anxiolytic activity.</p>Fórmula:C25H23ClN4O4Pureza:97.79% - 99.07%Cor e Forma:SolidPeso molecular:478.93CH-100
CAS:<p>CH-100 is a Chinese herbal medicine previously used in the treatment of human hepatitis C.</p>Fórmula:C14H22ClNO3Cor e Forma:SolidPeso molecular:287.78DprE1-IN-8
CAS:<p>DprE1-IN-8 is a potent inhibitor of DprE1, exhibiting an IC50 of less than 0.75 μM.</p>Fórmula:C19H12F3N5O4SPureza:98%Cor e Forma:SolidPeso molecular:463.39Ref: TM-T79628
Produto descontinuadoFGFR1 inhibitor-10
CAS:<p>FGFR1 inhibitor-10 (Compound 4i), with an IC50 of 28 nM, effectively inhibits FGFR1 phosphorylation.</p>Fórmula:C26H30F3N7O2SPureza:98%Cor e Forma:SolidPeso molecular:561.62Ref: TM-T79686
Produto descontinuadoNeurokinin antagonist 1
CAS:<p>Neurokinin antagonist 1 is a potent is a neuropeptide antagonist that can be used to study neurological disorders.</p>Fórmula:C38H40N4O3Pureza:>99.99%Cor e Forma:SolidPeso molecular:600.75Anti-NASH agent 1
CAS:<p>Anti-NASH Agent 1 (Compound 3d), derived from Elafibranor, serves as a strong PPAR-α/δ agonist aimed at treating nonalcoholic steatohepatitis (NASH).</p>Fórmula:C26H33NO4Pureza:98%Cor e Forma:SolidPeso molecular:423.54Ref: TM-T79454
Produto descontinuadoSR14150
CAS:<p>SR14150 is a partial agonist of high-affinity NOP receptor.</p>Fórmula:C21H30N2OPureza:98%Cor e Forma:SolidPeso molecular:326.48Lp-PLA2-IN-16
CAS:<p>Lp-PLA2-IN-16 (Example 1) is an inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2) with potential applications in Alzheimer's disease research [1].</p>Fórmula:C22H17F5N4O3Pureza:98%Cor e Forma:SolidPeso molecular:480.39Ref: TM-T79076
Produto descontinuadoCGP 44532
CAS:<p>CGP 44532 a GABAB receptor agonist.</p>Fórmula:C4H12NO3PPureza:98%Cor e Forma:SolidPeso molecular:153.12DPX-3778
CAS:<p>DPX-3778, a triethanolamine salt, boosts tobacco callus growth 4-5x at 0.124-2.48 μM and slows aging with IAA and kinetin.</p>Fórmula:C16H23ClN4O6Cor e Forma:SolidPeso molecular:402.83PL265
CAS:<p>PL265 is a long-acting dual ENKephalinase inhibitor (DENKi) with analgesic potential.</p>Fórmula:C27H35N2O9PPureza:98%Cor e Forma:SolidPeso molecular:562.55anti-TNBC agent-2
CAS:<p>Anti-TNBC agent-2 (3j), a purine derivative, acts as an anti-triple negative breast cancer (TNBC) therapeutic.</p>Fórmula:C28H37ClFN7OPureza:98%Cor e Forma:SolidPeso molecular:542.09Ref: TM-T79699
Produto descontinuadoGlutaminyl Cyclase Inhibitor 4
CAS:<p>Glutaminyl Cyclase Inhibitor 4 is a potent, selective glutaminyl cyclase (QC) inhibitor (IC50: 6.1 nM). It is a potent anti-Alzheimer’s agent.</p>Fórmula:C22H33N5O3Pureza:98%Cor e Forma:SolidPeso molecular:415.53Lp-PLA2-IN-15
CAS:<p>Lp-PLA2-IN-15 (example 2) is an inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2) with potential application in Alzheimer's disease research [1].</p>Fórmula:C22H17F5N4O3Pureza:98%Cor e Forma:SolidPeso molecular:480.39Ref: TM-T79075
Produto descontinuadoCK176
CAS:<p>CK176 is an HIV-1 inhibitor, 11x more effective than I-XW-053 in human PBMCs.</p>Fórmula:C21H12IN3O2Pureza:98%Cor e Forma:SolidPeso molecular:465.24ALPK1-IN-2
CAS:<p>ALPK1-IN-2 is a potent inhibitor of ALPK1 (α-kinase 1) (IC50: 95 nM). ALPK1-IN-2 inhibits NF-κB (IC50: 1.31 μM).</p>Fórmula:C20H18F2N4O2SCor e Forma:SolidPeso molecular:416.44Ref: TM-T62162
Produto descontinuadoMitoE10
CAS:<p>MitoE10 is an effective mitochondrial targeting antioxidant.</p>Fórmula:C42H55O5PSCor e Forma:SolidPeso molecular:702.92BCR-ABL-IN-8
CAS:<p>BCR-ABL-IN-8 (compound 26f) is a BCR-ABL inhibitor featuring a trimethoxy group [1].</p>Fórmula:C30H33N7O5Pureza:98%Cor e Forma:SolidPeso molecular:571.63CYY292
CAS:<p>CYY292 is a chemical compound acting as an inhibitor of PDGFRα, PDGFRβ, FGFR1, -2, and -3, with respective IC50 values of 5.35, 4.6, 28, 28, and 78 nM.</p>Fórmula:C24H28N8OCor e Forma:SolidPeso molecular:444.53JAK1-IN-11
CAS:<p>JAK1-IN-11 (compound 11) serves as a potent inhibitor of Janus kinases, exhibiting nanomolar inhibitory concentrations with IC50 values of 0.02 nM (JAK1) and 0.</p>Fórmula:C26H36N6O4SPureza:98%Cor e Forma:SolidPeso molecular:528.67Anti-MI/R injury agent 1
CAS:<p>Anti-MI/R injury agent 1 (compound 18), derived from Panaxatriol, represents an orally administered, potent agent against myocardial ischemia/reperfusion (MI/R</p>Fórmula:C32H49NO6Cor e Forma:SolidPeso molecular:543.73CIAC001
CAS:<p>CIAC001, a pyruvate kinase PKM2 inhibitor, exhibits anti-neuroinflammatory properties.</p>Fórmula:C20H25N3O2Cor e Forma:SolidPeso molecular:339.43APG-2449
CAS:<p>APG-2449 is an orally active inhibitor targeting ALK, ROS1, and FAK, demonstrating antitumor efficacy in mouse models of non-small cell lung cancer (NSCLC) [1].</p>Fórmula:C33H42ClN5O4SPureza:98%Cor e Forma:SolidPeso molecular:640.24Ref: TM-T79363
Produto descontinuadoEST73502
CAS:<p>EST73502 is a compound that functions as a dual agonist for the μ-opioid receptor (MOR) and an antagonist for the σ1 receptor (σ1R). It is selective, orally active, and possesses the ability to penetrate the blood-brain barrier (BBB). The compound exhibits a Ki value of 64 nM for the MOR and 118 nM for the σ1R. Additionally, EST73502 demonstrates antinociceptive activity [1].</p>Fórmula:C19H26F2N2O2Pureza:98%Cor e Forma:SolidPeso molecular:352.426Estrogen receptor modulator 8
CAS:<p>Estrogen Receptor Modulator 8 (compound 4) is an orally active inhibitor targeting Estrogen Receptor/ERR α with potent efficacy (IC50 = 0.437 nM in MCF-7 cells</p>Fórmula:C25H24F4N2O2Pureza:98%Cor e Forma:SolidPeso molecular:460.46Antitumor agent-104
CAS:<p>Antitumor Agent-104 (Compound 9) serves as an antineoplastic by impeding DNA repair mechanisms in tumor cells, primarily through the inhibition of PARP1 enzyme</p>Fórmula:C31H33FN6O3Pureza:98%Cor e Forma:SolidPeso molecular:556.63Antitumor photosensitizer-1
CAS:<p>Antitumor Photosensitizer-1 (Compound 8) is a potent photosensitizer with remarkable photodynamic anti-tumor properties and minimal skin photo-toxicity,</p>Fórmula:C42H51N5O6Cor e Forma:SolidPeso molecular:721.88Sakura 6
CAS:<p>Sakura 6, a synthetic serotonin transporter (SERT)-binding peptide, enhances the interaction between SERT and neuronal nitric oxide synthase.</p>Fórmula:C31H45N5O7Cor e Forma:SolidPeso molecular:599.73Bumetanide sodium
CAS:<p>Bumetanide sodium, a potent diuretic, blocks NKCC1 (IC50: 0.68 μM) and NKCC2 (IC50: 4.0 μM).</p>Fórmula:C17H19N2NaO5SCor e Forma:SolidPeso molecular:386.4DiaFluo
CAS:<p>DiaFluo is a probe for protein S-sulfinylation from cells.</p>Fórmula:C32H32N4O9SCor e Forma:SolidPeso molecular:648.69Ref: TM-T31416
Produto descontinuadoBET-IN-14
CAS:<p>BET-IN-14 is a pan BET inhibitor with an IC50 of 5.35 nM, demonstrating oral activity and anticancer properties [1].</p>Fórmula:C30H37N7O2Pureza:98%Cor e Forma:SolidPeso molecular:527.66LFS-1107
CAS:<p>LFS-1107, a reversible CRM1 inhibitor (Kd: 12.5 pM), selectively targets and eliminates ENKTL cells, offering potential for cancer research applications [1].</p>Fórmula:C12H11N5OS2Pureza:98%Cor e Forma:SolidPeso molecular:305.38DPP
CAS:<p>DPP, a Platinum(IV) complex with a pterostilbene-derived axial ligand, inhibits the JAK2-STAT3 pathway in breast cancer (BC) cells, demonstrating</p>Fórmula:C36H40Cl2N2O10PtPureza:98%Cor e Forma:SolidPeso molecular:926.7JAK-IN-34
CAS:<p>JAK-IN-34 (compound 11n) is a potent inhibitor of Janus kinases (JAKs), demonstrating IC50 values of 0.40 nM for JAK1, 0.83 nM for JAK2, 2.10 nM for JAK3,</p>Fórmula:C27H26N6OPureza:98%Cor e Forma:SolidPeso molecular:450.53Antitumor photosensitizer-2
CAS:<p>Compound 11, also known as Antitumor Photosensitizer-2, is a potent photosensitizer with remarkable photodynamic anti-tumor properties and minimal skin photo-</p>Fórmula:C40H47N5O7Cor e Forma:SolidPeso molecular:709.83diMal-O-CH2COOH
CAS:<p>DiMal-O-CH2COOH is a cleavable linker utilized in antibody-drug conjugates (ADCs).</p>Fórmula:C13H12N2O7Cor e Forma:SolidPeso molecular:308.24URAT1&XO inhibitor 1
CAS:<p>URAT1&XO Inhibitor 1 (compound 29) serves as a dual inhibitor with IC50 values of approximately 10 μM for URAT1 and 1.01 μM for Xanthine Oxidase.</p>Fórmula:C20H13N5O3SPureza:98%Cor e Forma:SolidPeso molecular:403.41Ref: TM-T79175
Produto descontinuadoTrkB-IN-1
CAS:<p>TrkB-IN-1 is a potent, orally active agonist of the TrkB receptor, with favorable pharmacokinetic (PK) properties.</p>Fórmula:C19H16N2O6Pureza:98%Cor e Forma:SolidPeso molecular:368.34VMAT2-IN-2 tosylate
CAS:<p>VMAT2-IN-2 tosylate is a potent inhibitor of VMAT2 and is applicable in the research of tardive dyskinesia [1].</p>Fórmula:C27H36F3NO6SPureza:98%Cor e Forma:SolidPeso molecular:559.64Ref: TM-T79061
Produto descontinuadoL 689037
CAS:<p>L 689037 is an inhibitor of leukotriene biosynthesis.</p>Fórmula:C36H37ClN2O4Pureza:98%Cor e Forma:SolidPeso molecular:597.14Canlitinib
CAS:<p>Canlitinib, a tyrosine kinase inhibitor, holds potential for cancer research.</p>Fórmula:C33H31F2N3O7Pureza:98%Cor e Forma:SolidPeso molecular:619.61HBV-IN-38
CAS:<p>HBV-IN-38 (Example 193), an HBV DNA inhibitor with an EC50 value of ≤100 nM, serves as a research tool for investigating viral infections [1].</p>Fórmula:C18H16F3N5O4S2Pureza:98%Cor e Forma:SolidPeso molecular:487.48VISTA-IN-2
CAS:<p>VISTA-IN-2 (Compound 1) is a V-domain Ig suppressor of T-cell activation (VISTA) inhibitor that promotes the degradation of VISTA in cells via autophagy,</p>Fórmula:C23H23N3OPureza:98%Cor e Forma:SolidPeso molecular:357.45Ref: TM-T79653
Produto descontinuadoLT-540-717
CAS:<p>LT-540-717 (compound 32), a potent FLT3 inhibitor (IC50=0.62 nM), exhibits antiproliferative activity and effectively inhibits various acquired FLT3 mutations,</p>Fórmula:C24H24N8O2Cor e Forma:SolidPeso molecular:456.5Belfosdil
CAS:<p>Belfosdil is a blocker of antihypertensive calcium channel.</p>Fórmula:C27H50O7P2Pureza:98%Cor e Forma:SolidPeso molecular:548.63FLT3-IN-19
CAS:<p>FLT3-IN-19 (Comp 50) is a potent, selective inhibitor of FLT3, demonstrating an IC50 value of 0.213 nM, and is applicable in research pertaining to acute</p>Fórmula:C22H26N8OCor e Forma:SolidPeso molecular:418.49DDO-2213
CAS:<p>DDO-2213 is a potent, orally active inhibitor of the WDR5-MLL1 interaction, demonstrating an IC50 of 29 nM and a Kd of 72.9 nM against WDR5.</p>Fórmula:C24H27ClFN7OCor e Forma:SolidPeso molecular:483.97Lerzeparib
CAS:<p>Lerzeparib is a PARP (ADP-ribose polymerase) inhibitor that exhibits antineoplastic activity [1].</p>Fórmula:C21H20FN3O2Pureza:98%Cor e Forma:SolidPeso molecular:365.4RIOK2-IN-2
CAS:<p>RIOK2-IN-2 (8) functions as an inhibitor of RIOK2, exhibiting IC50 values of 3.02 μM in MKN-1 cells and 5.34 μM in MOLT4 cells [1].</p>Fórmula:C27H23F3N6O2Cor e Forma:SolidPeso molecular:520.51URAT1 inhibitor 5
CAS:<p>URAT1 Inhibitor 5 (compound 16) serves as a powerful inhibitor of URAT1 and is utilized in hyperuricemia research [1].</p>Fórmula:C18H14BrN3O2SCor e Forma:SolidPeso molecular:416.29Tibremciclib
CAS:<p>Tibremciclib is a cyclin-dependent kinase 4 (CDK4) inhibitor that exhibits antineoplastic properties [1].</p>Fórmula:C28H32F2N8Pureza:98%Cor e Forma:SolidPeso molecular:518.6S1P1 agonist 6
CAS:<p>Compound I (S1P1 agonist 6) is an S1P1 agonist that mitigates autoimmune activity by inhibiting lymphocyte trafficking and has potential as an immunosuppressive</p>Fórmula:C25H26F3NO3Pureza:98%Cor e Forma:SolidPeso molecular:445.47I-BET282
CAS:<p>BET-IN-1 is a bromodomain inhibitor extracted from patent WO/2013024104A1 (example 2, plC50: 6.0 - 7.0).</p>Fórmula:C25H30N4O4Pureza:98%Cor e Forma:SolidPeso molecular:450.53SHP2-IN-14
CAS:<p>SHP2-IN-14 (compound 27) is a potent, orally active allosteric inhibitor of SHP2, displaying strong anti-tumor activity with an IC50 of 7 nM.</p>Fórmula:C22H20Cl2N8OCor e Forma:SolidPeso molecular:483.35And1-IN-1
CAS:<p>And1-IN-1, also known as compound III, is a potent inhibitor of And1 [1].</p>Fórmula:C15H11BCl2O2Cor e Forma:SolidPeso molecular:304.96Yhhu6669
CAS:<p>Yhhu6669 is an anti-HBV agent that suppresses viral DNA and replication by promoting DNA-free capsid assembly, effectively reducing HBV DNA and HBcAg levels in</p>Fórmula:C29H28ClFN6O3Pureza:98%Cor e Forma:SolidPeso molecular:563.02Ref: TM-T78756
Produto descontinuadoSTAT3-IN-18
CAS:<p>STAT3-IN-18 (compound SPP), a platinum (IV) complex featuring an axial ligand from sandalwood, suppresses the JAK2-STAT3 pathway in breast cancer (BC) cells and</p>Fórmula:C18H24Cl2N2O6PtPureza:98%Cor e Forma:SolidPeso molecular:630.38(αR)-Cyclopropaneacetamide-Exatecan
CAS:<p>(αR)-Cyclopropaneacetamide-Exatecan (compound 2-A), an Exenotecan derivative, serves as a cytotoxic agent that effectively inhibits the proliferation of U87MG</p>Fórmula:C29H28FN3O6Cor e Forma:SolidPeso molecular:533.55Xilmenolone
CAS:<p>Xilmenolone acts as a positive allosteric modulator of the GABA_A receptor [1].</p>Fórmula:C26H37N3O2Pureza:98%Cor e Forma:SolidPeso molecular:423.59Ref: TM-T78670
Produto descontinuadoOmeprazole acid
CAS:<p>Omeprazole treats GERD, ulcers, Zollinger-Ellison syndrome, prevents GI bleeding; it's a proton pump inhibitor.</p>Fórmula:C34H32N6Na2O10S2Cor e Forma:SolidPeso molecular:794.76BBDDL2059
CAS:<p>BBDDL2059 is a selective covalent inhibitor targeting EZH2, exhibiting an IC50 of 1.5 nM against the EZH2-Y641F mutant.</p>Fórmula:C27H36N4O4SPureza:98%Cor e Forma:SolidPeso molecular:512.66Ref: TM-T79200
Produto descontinuadoLM2I
CAS:<p>LM2I, a derivative of Spinosyn A (SPA), serves both as an argininosuccinate synthase (ASS1) enzyme activator and a tumor inhibitor through direct interaction</p>Fórmula:C47H77N3O11Cor e Forma:SolidPeso molecular:860.13MOR agonist-1
CAS:<p>MOR Agonist-1 is a μ-opioid receptor (MOR) agonist noted for its potent analgesic properties and is utilized in research concerning pain and associated</p>Fórmula:C22H26ClFN2O2Pureza:98%Cor e Forma:SolidPeso molecular:404.91ATR-IN-24
CAS:<p>ATR-IN-24 (Compound 1) is an ATR inhibitor with demonstrated anticancer activity [1].</p>Fórmula:C23H26N6O2Pureza:98%Cor e Forma:SolidPeso molecular:418.49Ref: TM-T79058
Produto descontinuadoS-72
CAS:<p>S-72 acts as a microtubule polymerization inhibitor, effective in cell-free assays at concentrations of 1, 3, and 10 µM.</p>Fórmula:C20H22N4O3SCor e Forma:SolidPeso molecular:398.50Ref: TM-T83874
Produto descontinuadoYK-029A
CAS:<p>YK-029A, an orally active EGFR mutant inhibitor, targets both EGFR T790M and EGFRex20ins mutations.</p>Fórmula:C27H32N8O2Pureza:98%Cor e Forma:SolidPeso molecular:500.6Ref: TM-T79461
Produto descontinuadoI5B2
CAS:<p>I5B2 is a novel phosphorus-containing angiotensin I converting enzyme inhibitor. Angiotensin I converting enzyme is produced by Actinomadura sp.</p>Fórmula:C23H32N3O7PPureza:98%Cor e Forma:SolidPeso molecular:493.49JAK1-IN-10
CAS:<p>JAK1-IN-10 (compound 9), a cyano-substituted cyclic hydrazine derivative, functions as a potent and selective inhibitor of JAK1 [1].</p>Fórmula:C15H17N7Pureza:98%Cor e Forma:SolidPeso molecular:295.34ALPK1-IN-3
CAS:<p>ALPK1-IN-3,serves as an ALPK1 inhibitor that dampens proinflammatory gene expression in the kidney and enhances survival in animal models of sepsis-induced</p>Fórmula:C20H16F2N4OSPureza:98%Cor e Forma:SolidPeso molecular:398.43Davelizomib
CAS:<p>Davelizomib is a proteasome inhibitor that exhibits antineoplastic activity [1].</p>Fórmula:C21H26BF2N3O7Pureza:98%Cor e Forma:SolidPeso molecular:481.25Cap-dependent endonuclease-IN-9
CAS:<p>Cap-dependent endonuclease-IN-9, a strong influenza inhibitor, shows low toxicity, good pharmacokinetics, and dynamic action.</p>Fórmula:C29H22F2N4O7SPureza:98%Cor e Forma:SolidPeso molecular:608.57Ref: TM-T72125
Produto descontinuadoAzilsartan mepixetil potassium
CAS:<p>Azilsartan medoxomil potassium (QR-01019K), an angiotensin II receptor antagonist, exhibits a potent and sustained antihypertensive effect, along with a more</p>Fórmula:C36H33KN6O8Cor e Forma:SolidPeso molecular:716.78SARS-CoV-2-IN-68
CAS:<p>SARS-CoV-2-IN-68 (compound 6C) is a covalent inhibitor of both SARS-CoV-2 PLpro and Mpro, exhibiting potent antiviral properties by targeting the Zn-finger</p>Fórmula:C14H12N2OSePureza:98%Cor e Forma:SolidPeso molecular:303.22CGP 56999A
CAS:<p>CGP 56999A is a GABA(B) receptor antagonist; it boosts BDNF and reduces dopamine loss in rat striatum.</p>Fórmula:C19H30NO5PPureza:98%Cor e Forma:SolidPeso molecular:383.42Igermetostat
CAS:<p>Igermetostat, an EZH2 inhibitor, is utilized both in vivo and in vitro for cancer research [1].</p>Fórmula:C32H46N4O4Pureza:98%Cor e Forma:SolidPeso molecular:550.73Syk-IN-8
CAS:<p>Syk-IN-8 (compound 19q) functions as a Syk inhibitor with demonstrated antiproliferative effects on a variety of hematological tumor cells.</p>Fórmula:C23H26N10Pureza:98%Cor e Forma:SolidPeso molecular:442.52PF-05236216 hydrochloride
CAS:<p>PF-05236216 hydrochloride: Brain-penetrant, potent CK1δ/ε inhibitor affecting mouse circadian rhythms.</p>Fórmula:C18H15FN4OCor e Forma:SolidPeso molecular:322.34Civorebrutinib
CAS:<p>Civorebrutinib (WS-413) is an inhibitor of Bruton's tyrosine kinase that exhibits antineoplastic activity [1].</p>Fórmula:C23H22ClN7O2Cor e Forma:SolidPeso molecular:463.92HPK1-IN-38
CAS:<p>HPK1-IN-38 (compound 15) is an inhibitor of MAP4K1/HPK1, suitable for research into disorders related to HPK1 [1].</p>Fórmula:C29H29N5O3Cor e Forma:SolidPeso molecular:495.57Tauro-Obeticholic Acid sodium
CAS:<p>Tauro-obeticholic acid, a farnesoid X receptor (FXR) agonist and semisynthetic derivative of chenodeoxycholic acid, is an active metabolite of obeticholic acid.</p>Fórmula:C28H48NO6S·NaCor e Forma:SolidPeso molecular:549.74MDL-811
CAS:<p>MDL-811, an allosteric activator of SIRT6, markedly enhances the deacetylation of histone H3 at lysine residues 9, 18, and 56 (H3K9Ac, H3K18Ac, and H3K56Ac),</p>Fórmula:C25H25BrCl2FN3O5S2Pureza:98%Cor e Forma:SolidPeso molecular:681.42Mal-VC-PAB-PNP-CDN-A
CAS:<p>Mal-VC-PAB-PNP-CDN-A is a conjugate comprised of an agent and a linker, utilized in antibody-drug conjugates (ADC) [1] [2].</p>Fórmula:C51H67N17O20P2Cor e Forma:SolidPeso molecular:1300.13FAP-IN-2
CAS:<p>FAP-IN-2 is a 99mTc-labeled, isonitrile-containing derivative of a fibroblast activation protein (FAPI) inhibitor suitable for tumor imaging [1].</p>Fórmula:C24H28F2N6O3Cor e Forma:SolidPeso molecular:486.51IDO1-IN-22
CAS:<p>IDO1-IN-22 (Compound 3) is an inhibitor of IDO1, demonstrating potent activity with biochemical hIDO1 IC50 of 67.4 nM and HeLa hIDO1 IC50 of 17.6 nM.</p>Fórmula:C12H12BrFN6O3Pureza:98%Cor e Forma:SolidPeso molecular:387.16Bi-Mc-VC-PAB-MMAE
CAS:<p>Bi-Mc-VC-PAB-MMAE is an agent-linker conjugate for antibody-drug conjugates (ADCs), featuring the linker (Fmoc-Val-Cit-PAB) and the potent tubulin inhibitor (</p>Fórmula:C71H104N12O18Cor e Forma:SolidPeso molecular:1413.66
